These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9478315)

  • 1. 17-alpha-Hydroxyprogesterone caproate and natural progesterone in assisted reproduction: a comparative study.
    Abate A; Brigandì A; Costabile L; Abate FG; Balzano E; Perino M
    Clin Exp Obstet Gynecol; 1997; 24(4):190-2. PubMed ID: 9478315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study.
    Unfer V; Casini ML; Costabile L; Gerli S; Baldini D; Di Renzo GC
    Reprod Biomed Online; 2004 Jul; 9(1):17-21. PubMed ID: 15257811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteal phase support with 17alpha-hydroxyprogesterone versus unsupported cycles in in vitro fertilization: a comparative randomized study.
    Abate A; Brigandi A; Abate FG; Manti F; Unfer V; Perino M
    Gynecol Obstet Invest; 1999; 48(2):78-80. PubMed ID: 10460994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles.
    Costabile L; Gerli S; Manna C; Rossetti D; Di Renzo GC; Unfer V
    Fertil Steril; 2001 Aug; 76(2):394-6. PubMed ID: 11476795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Analysis of Outcomes Between Two Different Intramuscular Progesterone Preparations in Women Undergoing Frozen Embryo Transfer Cycles.
    Seshadri S; Odia R; Ozturk O; Saab W; AlChami A; Gonzalez XV; Salim S; Saab W; Serha P
    J Reprod Infertil; 2022; 23(1):46-53. PubMed ID: 36045879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program.
    Artini PG; Volpe A; Angioni S; Galassi MC; Battaglia C; Genazzani AR
    J Endocrinol Invest; 1995 Jan; 18(1):51-6. PubMed ID: 7759785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester bleeding in clinical IVF pregnancies.
    Goldman JA; Ashkenazi J; Ben-David M; Feldberg D; Dicker D; Voliovitz I
    Hum Reprod; 1988 Aug; 3(6):807-9. PubMed ID: 3220946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience with steroidal ovarian suppression for prevention of severe ovarian hyperstimulation syndrome in IVF patients.
    Rjosk HK; Abendstein BJ; Kreuzer E; Schwärzler P
    Hum Fertil (Camb); 2001; 4(4):246-8. PubMed ID: 11719720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular versus vaginal progesterone in assisted reproduction: a comparative study.
    Perino M; Brigandì FG; Abate FG; Costabile L; Balzano E; Abate A
    Clin Exp Obstet Gynecol; 1997; 24(4):228-31. PubMed ID: 9478327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support of the luteal phase in in vitro fertilization programs: results of a controlled trial with intramuscular Proluton.
    Leeton J; Trounson A; Jessup D
    J In Vitro Fert Embryo Transf; 1985 Sep; 2(3):166-9. PubMed ID: 3932570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of hydroxyprogesterone caproate to maintain pregnancy in ovariectomised mares.
    McKinnon AO; Tarrida del Marmol Figueroa S; Nobelius AM; Hyland JH; Vasey JR
    Equine Vet J; 1993 Mar; 25(2):158-60. PubMed ID: 8467776
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 17 alpha-hydroxyprogesterone caproate/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: a prospective and randomized controlled trial.
    Prietl G; Diedrich K; van der Ven HH; Luckhaus J; Krebs D
    Hum Reprod; 1992 Jun; 7 Suppl 1():1-5. PubMed ID: 1332985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F; Vaccaro V
    Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Injectable progesterone in hormone replacement therapy in menopause].
    Patacchiola F; Porzio G; Carta G; Mascaretti G; Palermo P; Silani S; Di Stefano LM; Moscarini M
    Clin Ter; 1998; 149(6):425-7. PubMed ID: 10100404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
    Bustos ML; Caritis SN; Jablonski KA; Reddy UM; Sorokin Y; Manuck T; Varner MW; Wapner RJ; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM;
    Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
    Onsrud M
    Gynecol Oncol; 1982 Dec; 14(3):355-64. PubMed ID: 6983994
    [No Abstract]   [Full Text] [Related]  

  • 19. Luteal phase progesterone supplementation following induced natural cycle frozen embryo transfer: A retrospective cohort study.
    Schwartz E; Bernard L; Ohl J; Bettahar K; Rongières C; Lichtblau I; Pirrello O
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):95-98. PubMed ID: 30347257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of severe ovarian hyperstimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression--a prospective randomized study.
    Schwärzler P; Abendstein BJ; Klingler A; Kreuzer E; Rjosk HK
    Hum Fertil (Camb); 2003 Aug; 6(3):125-9. PubMed ID: 12960445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.